Detection of circulating prostatic cells during radical prostatectomy

被引:17
作者
Planz, B
Szyska, P
Valdor, M
Boeckmann, W
Fuzesi, L
Jakse, G
机构
[1] Aachen Tech Univ, Urol Clin, D-52057 Aachen, Germany
[2] Aachen Tech Univ, Inst Pathol, D-52057 Aachen, Germany
来源
UROLOGICAL RESEARCH | 1997年 / 25卷 / 06期
关键词
prostate cancer; flow cytometry; circulating prostatic cells;
D O I
10.1007/BF01268852
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The detection of micrometastasis of prostate cancer could help to decide more appropriate therapeutic strategies in an individual patient. We have developed a flow cytometric method for detecting cytokeratin-positive cells in the peripheral blood before, during and after radical prostatectomy in patients with prostatic carcinoma. By means Of this technique we were able to detect a higher number of cytokeratin-positive cells in the intraoperative blood sample than in the pre-and postoperative blood sample in 15 patients with prostate cancer (P < 0.05). Out results show an increase in the number of cytokeratin-positive cells with increasing tumor stage and grade, as well a good correlation of prostate-specific antigen (PSA) value with the number of cytokeratin-positive cells (r > 0.6). Our results underline the importance of no-touch techniques at prostatectomy to minimize release of tumor cells into the circulation during surgery. In the light of our results we consider that the indication for cell savers during radical prostatectomy should be reevaluated. The possibility of detecting single metastatic cells in peripheral blood will enable better individual patient management, and open up new modalities for diagnosing early prostate cancer and enhancing patient monitoring in relapse and tumor progression.
引用
收藏
页码:385 / 389
页数:5
相关论文
共 23 条
[1]  
BRAWER MK, 1985, CANCER RES, V45, P3663
[2]   MOLECULAR STAGING OF PROSTATE-CANCER .2. A COMPARISON OF THE APPLICATION OF AN ENHANCED REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION ASSAY FOR PROSTATE-SPECIFIC ANTIGEN VERSUS PROSTATE-SPECIFIC MEMBRANE ANTIGEN [J].
CAMA, C ;
OLSSON, CA ;
RAFFO, AJ ;
PERLMAN, H ;
BUTTYAN, R ;
OTOOLE, K ;
MCMAHON, D ;
BENSON, MC ;
KATZ, AE .
JOURNAL OF UROLOGY, 1995, 153 (05) :1373-1378
[3]   PREDICTING RADIONUCLIDE BONE-SCAN FINDINGS IN PATIENTS WITH NEWLY DIAGNOSED, UNTREATED PROSTATE-CANCER - PROSTATE SPECIFIC ANTIGEN IS SUPERIOR TO ALL OTHER CLINICAL-PARAMETERS [J].
CHYBOWSKI, FM ;
KELLER, JJL ;
BERGSTRALH, EJ ;
OESTERLING, JE .
JOURNAL OF UROLOGY, 1991, 145 (02) :313-318
[4]   SEPARATION OF MALIGNANT-CELLS DURING AUTO-TRANSFUSION [J].
DALE, RF ;
KIPLING, RM ;
SMITH, MF ;
COLLIER, DS ;
SMITH, PJ .
BRITISH JOURNAL OF SURGERY, 1988, 75 (06) :581-581
[5]  
DENK H, 1987, HUMAN TUMOR MARKERS, P333
[6]  
FAUL P, 1989, UROLOGE A, V28, P88
[7]  
FROST P, 1986, Cancer, V58, P550, DOI 10.1002/1097-0142(19860715)58:2+<550::AID-CNCR2820581324>3.0.CO
[8]  
2-Z
[9]  
GHOSSEIN R, 1994, P AM SOC CLIN ONCOL, V13, P237
[10]   CIRCULATING PROSTATE SPECIFIC ANTIGEN-POSITIVE CELLS CORRELATE WITH METASTATIC PROSTATE-CANCER [J].
HAMDY, FC ;
LAWRY, J ;
ANDERSON, JB ;
PARSONS, MA ;
REES, RC ;
WILLIAMS, JL .
BRITISH JOURNAL OF UROLOGY, 1992, 69 (04) :392-396